BridgeBio Pharma Stock (NASDAQ: BBIO) stock price, news, charts, stock research, profile.
Open | $25.02 |
Close | $25.00 |
Volume / Avg. | 1.02M / 1.98M |
Day Range | 24.71 - 25.48 |
52 Wk Range | 16.61 - 44.32 |
Market Cap | $4.79B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 13.74% |
Days to Cover | 10.42 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.
Other companies in BridgeBio Pharma’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
There is no analysis for BridgeBio Pharma.
BridgeBio Pharma has a consensus price target of $40.50.
The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $25.6 last updated July 3, 2024 at 4:58 PM EDT.
There are no upcoming dividends for BridgeBio Pharma.
BridgeBio Pharma’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for BridgeBio Pharma.
BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.